- [Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options].
[Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options].
Deutsche medizinische Wochenschrift (1946) (2014-05-08)
G J Molderings, J Homann, S Brettner, M Raithel, T Frieling
PMID24801454
RÉSUMÉ
In the present paper clinical phenotypes, pathogenetic relationships, and diagnostic algorithms as well as therapeutic concepts of/for systemic mast cell activation disease are reviewed. The reader should be able to recognize and diagnose a systemic mast cell activation disease, as well as to counsel a personalized drug therapy. In the case of chronic multisystem polymorbidity systemic mast cell activation disease should be considered as a differential diagnosis at an early stage. In most cases, specific, little invasive investigations allow diagnosing the disease and, hence, an appropriate therapy can be initiated.
MATÉRIAUX
Référence du produit
Marque
Description du produit
Sigma-Aldrich
L-acide ascorbique, suitable for cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
L-acide ascorbique, puriss. p.a., ACS reagent, reag. ISO, Ph. Eur., 99.7-100.5% (oxidimetric)
Supelco
Lascorbate de (+)-sodium, Pharmaceutical Secondary Standard; Certified Reference Material
L-acide ascorbique, European Pharmacopoeia (EP) Reference Standard
Lascorbate de (+)-sodium, European Pharmacopoeia (EP) Reference Standard
Supelco
L-acide ascorbique, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Ketotifen hydrogen fumarate, European Pharmacopoeia (EP) Reference Standard
Supelco
Ranitidine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Ranitidine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Ketotifen for peak identification, European Pharmacopoeia (EP) Reference Standard